Total Funding
77
17
Total FundingVenture - Series Unknown raised
Growth Score
-9 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2252262
Deltagen provides drug discovery tools and services for the biopharmaceutical industry and academic research community in the United States.
Daniel Ratto: CFO- Robert Driscoll: President & CEOPast Role: Deltagen, Vice President, Intellectual Property & Legal Affairs
About the Company
Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States.
The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets.
It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.
